English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1453]
News [2223]
Articles [39]
Editorials [5]
Conferences [150]
elearning [0]
FDA approves pembrolizumab for adjuvant treatment of renal cell carcinoma
FDA approves pembrolizumab for adjuvant treatment of renal cell carcinoma
Giving immunotherapy before targeted therapy improves survival in advanced melanoma
Giving immunotherapy before targeted therapy improves survival in advanced melanoma
Results from a French study indicate that the COVID-19 vaccine is effective in patients with lung cancer
Results from a French study indicate that the COVID-19 vaccine is effective in patients with lung cancer
FDA approve clinical trial of drug to treat eye cancer ‘from the inside out’
FDA approve clinical trial of drug to treat eye cancer ‘from the inside out’
Average survival time has doubled for patients with two out of three types of advanced breast cancer in the past decade
Average survival time has doubled for patients with two out of three types of advanced breast cancer in the past...
Machine learning model uses clinical and genomic data to predict immunotherapy effectiveness
Machine learning model uses clinical and genomic data to predict immunotherapy effectiveness
FDA approves asciminib for Philadelphia chromosome-positive chronic myeloid leukaemia 
FDA approves asciminib for Philadelphia chromosome-positive chronic myeloid leukaemia 
Vulnerable populations not receiving cancer survivorship care plans
Vulnerable populations not receiving cancer survivorship care plans
Nivolumab + chemotherapy receives European commission approval for patients with HER2 negative, advanced or metastatic gastric, gastroesophageal junction or oesophageal adenocarcinoma
Nivolumab + chemotherapy receives European commission approval for patients with HER2 negative, advanced or...
Challenges and recommendations for real-world evidence in oncology: Focus on Central and Eastern Europe
Challenges and recommendations for real-world evidence in oncology: Focus on Central and Eastern Europe
<1...7576777879...223>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top